Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Action
- Medical device cancellation (827)
- Medicine suspension (472)
- Complementary medicine cancellation (203)
- Medical device suspension (86)
- Medicine cancellation (59)
- Revocation of a TGA issued Conformity Assessment Certificate (51)
- Medical device cancellation - certain devices within an entry (22)
- Registered medicine cancellation (12)
- Voluntary revocation at the request of the manufacturer (9)
- Medical device cancellation - requested by the sponsor - certain devices within an entry (8)
- Medical device cancellation (7)
- Listed medicine cancellation (3)
- Listed medicine cancellation (3)
- Revocation of a TGA issued Conformity Assessment Certificate. (3)
- Revocation of medical device suspension (2)
- Revoked medicine suspension (2)
- Medical device cancellation (1)
- Medical device cancellation – certain devices within an entry (1)
- Suspension from the ARTG under subsection s41GA(1)(b) (1)
- Voluntary revocation at the request of the manufacturer. (1)
Find out more about Cancellations and Suspensions.
Results for
"[search-keyword]"
Search
1780 result(s) found, displaying 751 to 775
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/06/2021
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/06/2021
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/06/2021
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/06/2021
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/06/2021
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/06/2021
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/06/2021
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/06/2021
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/06/2021
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/06/2021
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/06/2021
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/06/2021
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/06/2021
-
Cancellation or suspensionRegulatory action due to Non response to a s41JA, effective 16/06/2021
-
Cancellation or suspensionRegulatory action due to Non response to a s41JA, effective 16/06/2021
-
Cancellation or suspensionRegulatory action due to Non response to a s41JA, effective 16/06/2021
-
Cancellation or suspensionRegulatory action due to Non response to a s41JA, effective 16/06/2021
-
Cancellation or suspensionRegulatory action due to Non response to a s41JA, effective 16/06/2021
-
Cancellation or suspensionRegulatory action due to Non response to a s41JA, effective 16/06/2021
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply with an automatic condition of inclusion under subsection 41FN(5A) of the Act. The sponsor did not provide information to the TGA about that kind of medical device on an annual basis for the first three years of the kind of device’s inclusion. The TGA notified the sponsor of the cancellation on 13 May 2021. On 21 May 2021, the sponsor voluntarily cancelled the ARTG inclusion., effective 11/06/2021
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply with an automatic condition of inclusion under subsection 41FN(5A) of the Act. The sponsor did not provide information to the TGA about that kind of medical device on an annual basis for the first three years of the kind of device's inclusion. The TGA notified the sponsor of the cancellation on 13 May 2021. On 21 May 2021, the sponsor voluntarily cancelled the ARTG inclusion., effective 11/06/2021
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply with an automatic condition of inclusion under subsection 41FN(5A) of the Act. The sponsor did not provide information to the TGA about that kind of medical device on an annual basis for the first three years of the kind of device's inclusion. The TGA notified the sponsor of the cancellation on 13 May 2021. On 21 May 2021, the sponsor voluntarily cancelled the ARTG inclusion., effective 11/06/2021
-
Cancellation or suspensionRegulatory action due to The sponsor did not provide information to substantiate compliance with the Essential Principles, the sponsor failed to comply with a condition to which inclusion of the kind of device in the ARTG was subject under s.41FN(3)(a)., effective 07/06/2021
-
Cancellation or suspensionRegulatory action due to Non response to a s41JA, effective 17/05/2021
-
Cancellation or suspensionRegulatory action due to Non response to a s41JA, effective 17/05/2021